Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
An interview with Dr. Sharon Giordano, co-chair on "Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guidel...
10 Dec 20218min
Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)
An interview with Dr. Leslie Fecher from the University of Michigan Health System, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ...
16 Nov 20218min
Ocular Toxicities: Management of irAEs Guideline (Part 12)
An interview with Dr. Marc Ernstoff from the National Cancer Institute, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidel...
15 Nov 20216min
Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)
An interview with Dr. Pauline Funchain from Cleveland Clinic, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update...
12 Nov 202112min
Hematologic Toxicities: Management of irAEs Guideline (Part 10)
An interview with Dr. Loretta Nastoupil from MD Anderson Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidel...
11 Nov 202118min
Nervous System Toxicities: Management of irAEs Guideline (Part 9)
An interview with Dr. Bianca Santomasso from Memorial Sloan Kettering Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy...
10 Nov 202120min
Renal Toxicities: Management of irAEs Guideline (Part 8)
An interview with Dr. Umang Swami from the Huntsman Cancer Institute, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidelin...
9 Nov 202110min
Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)
An interview with Dr. Maria Suarez-Almazor from MD Anderson Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Gui...
8 Nov 202110min
